Table 1 |
|||||
|
Overview of selected protein profiling technologies |
|||||
|
Technology |
Type of labeling required |
Ability to detect many post-translational modifications |
Biomolecules that are optimally quantified |
Approximate dynamic range (and reference) |
Number of proteins/spots quantified (and reference) |
|
|
|||||
|
Two-dimensional gel electrophoresis |
Silver staining |
Yes |
Naturally occurring forms of proteins larger than 10 kDa |
10 [9] |
1,500 [8] |
|
Differential two-dimensional fluorescence gel electrophoresis (DIGE) |
In vitro with Cy2, Cy3 or CY5 fluorophores at primary amines |
Yes |
Naturally occurring forms of proteins larger than 10 kDa |
10,000 [9] |
1,100 [51] |
|
SELDI- or MALDI-MS disease biomarker discovery |
None |
Yes |
Naturally occurring forms of proteins smaller than 10 kDa |
25 |
Not applicable |
|
Isotope-coded affinity tag (ICAT) - LC/MS |
In vitro with H1/D or C12/C13 ICAT reagent at cysteine |
No |
Cysteine-containing tryptic peptides from digests of protein extracts |
10,000* |
496 [18] |
|
N14/N15 - LC/MS |
In vivo at nitrogens in amino acids |
Yes |
Tryptic peptides from digests of protein extracts |
10,000 [19] |
872 [20] |
|
|
|||||
|
*Assumed to be similar to that for multidimensional protein identification. Abbreviations: SELDI-MS, surface-enhanced laser desorption ionization mass spectrometry; MALDI-MS, matrix-assisted laser desorption ionization mass spectrometry; LC/MS, liquid chromatography and mass spectrometry. |
|||||
|
Greenbaum et al. Genome Biology 2003 4:117 doi:10.1186/gb-2003-4-9-117 |
|||||